What clients say
Keeping our states informed. Simplifying the complex.
The CAA includes multiple policies impacting Medicaid and the healthcare system more broadly
Review of weight management medications and their impact on state Medicaid programs
Our review of Amjevita, the first Humira biosimilar, the 2023 biosimilar pipeline, and the impact to Medicaid
Bethany Holderread, Pharm.D. discusses therapies approved by the FDA within the last year
Learn how the Consolidated Appropriations Act, 2023 affects Medicaid and CHIP
CMS approves amendment to California’s 1115 waiver to allow for pre-release services to incarcerated individuals
Digital Therapeutics present challenges and opportunities for Medicaid programs
CMS announces a new policy framework for managed care in-lieu-of-services
Learn what's in store for 2023 and beyond
Working together to build a brighter future for state Medicaid agencies. We are unique in our mission to support our state partners in helping the most vulnerable populations.
Medicaid serves almost 86 million Americans. Hear one woman's brave journey after a devastating disability and how Medicaid impacted that journey. A reminder of why we work to support states.
Novel categories of ultra-high cost drugs called gene and cell therapy are entering the market. Some of the recent entrants have a price tag of $2-3 million per treatment.
Let's get social
Select the document(s) you wish to download from the "Our Insights" Drop Down Box below. Thank you!
Any information you provide will be used for internal purposes only.